Logo image of COR

CENCORA INC (COR) Stock Fundamental Analysis

NYSE:COR - New York Stock Exchange, Inc. - US03073E1055 - Common Stock - Currency: USD

241.43  -2.03 (-0.83%)

After market: 241.43 0 (0%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to COR. COR was compared to 108 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of COR while its profitability can be described as average. COR is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year COR was profitable.
COR had a negative operating cash flow in the past year.
Of the past 5 years COR 4 years were profitable.
In the past 5 years COR always reported a positive cash flow from operatings.
COR Yearly Net Income VS EBIT VS OCF VS FCFCOR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B

1.2 Ratios

COR has a Return On Assets of 2.02%. This is in the better half of the industry: COR outperforms 64.49% of its industry peers.
With an excellent Return On Equity value of 616.22%, COR belongs to the best of the industry, outperforming 99.07% of the companies in the same industry.
COR's Return On Invested Capital of 16.43% is amongst the best of the industry. COR outperforms 92.52% of its industry peers.
The Average Return On Invested Capital over the past 3 years for COR is significantly above the industry average of 8.14%.
Industry RankSector Rank
ROA 2.02%
ROE 616.22%
ROIC 16.43%
ROA(3y)2.68%
ROA(5y)0.61%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)16.51%
ROIC(5y)15.55%
COR Yearly ROA, ROE, ROICCOR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500

1.3 Margins

COR's Profit Margin of 0.46% is in line compared to the rest of the industry. COR outperforms 56.07% of its industry peers.
In the last couple of years the Profit Margin of COR has grown nicely.
With a Operating Margin value of 1.01%, COR perfoms like the industry average, outperforming 42.06% of the companies in the same industry.
In the last couple of years the Operating Margin of COR has remained more or less at the same level.
COR's Gross Margin of 3.26% is on the low side compared to the rest of the industry. COR is outperformed by 84.11% of its industry peers.
In the last couple of years the Gross Margin of COR has grown nicely.
Industry RankSector Rank
OM 1.01%
PM (TTM) 0.46%
GM 3.26%
OM growth 3Y-6.12%
OM growth 5Y-0.1%
PM growth 3Y-10.65%
PM growth 5Y1.52%
GM growth 3Y1.72%
GM growth 5Y3.69%
COR Yearly Profit, Operating, Gross MarginsCOR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1 -1 2 3

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), COR is creating value.
COR has less shares outstanding than it did 1 year ago.
COR has less shares outstanding than it did 5 years ago.
The debt/assets ratio for COR has been reduced compared to a year ago.
COR Yearly Shares OutstandingCOR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
COR Yearly Total Debt VS Total AssetsCOR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

COR has an Altman-Z score of 4.99. This indicates that COR is financially healthy and has little risk of bankruptcy at the moment.
COR has a Altman-Z score of 4.99. This is amongst the best in the industry. COR outperforms 83.18% of its industry peers.
A Debt/Equity ratio of 26.20 is on the high side and indicates that COR has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 26.20, COR is doing worse than 87.85% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 26.2
Debt/FCF N/A
Altman-Z 4.99
ROIC/WACC1.9
WACC8.63%
COR Yearly LT Debt VS Equity VS FCFCOR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

COR has a Current Ratio of 0.92. This is a bad value and indicates that COR is not financially healthy enough and could expect problems in meeting its short term obligations.
COR has a Current ratio of 0.92. This is in the lower half of the industry: COR underperforms 79.44% of its industry peers.
COR has a Quick Ratio of 0.92. This is a bad value and indicates that COR is not financially healthy enough and could expect problems in meeting its short term obligations.
COR has a Quick ratio of 0.54. This is amonst the worse of the industry: COR underperforms 87.85% of its industry peers.
Industry RankSector Rank
Current Ratio 0.92
Quick Ratio 0.54
COR Yearly Current Assets VS Current LiabilitesCOR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 13.14% over the past year.
Measured over the past years, COR shows a quite strong growth in Earnings Per Share. The EPS has been growing by 14.21% on average per year.
COR shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.64%.
The Revenue has been growing by 10.36% on average over the past years. This is quite good.
EPS 1Y (TTM)13.14%
EPS 3Y14.11%
EPS 5Y14.21%
EPS Q2Q%13.72%
Revenue 1Y (TTM)11.64%
Revenue growth 3Y11.16%
Revenue growth 5Y10.36%
Sales Q2Q%12.78%

3.2 Future

Based on estimates for the next years, COR will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.76% on average per year.
The Revenue is expected to grow by 7.34% on average over the next years.
EPS Next Y13.02%
EPS Next 2Y11.49%
EPS Next 3Y10.86%
EPS Next 5Y10.76%
Revenue Next Year9.66%
Revenue Next 2Y8.29%
Revenue Next 3Y7.76%
Revenue Next 5Y7.34%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
COR Yearly Revenue VS EstimatesCOR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 100B 200B 300B 400B
COR Yearly EPS VS EstimatesCOR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5 10 15 20

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 16.99 indicates a correct valuation of COR.
Based on the Price/Earnings ratio, COR is valued a bit cheaper than 75.70% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 29.63, COR is valued a bit cheaper.
The Price/Forward Earnings ratio is 14.12, which indicates a correct valuation of COR.
COR's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. COR is cheaper than 76.64% of the companies in the same industry.
COR's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.68.
Industry RankSector Rank
PE 16.99
Fwd PE 14.12
COR Price Earnings VS Forward Price EarningsCOR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, COR is valued a bit cheaper than the industry average as 66.36% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.44
COR Per share dataCOR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 500 1K 1.5K

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of COR may justify a higher PE ratio.
PEG (NY)1.31
PEG (5Y)1.2
EPS Next 2Y11.49%
EPS Next 3Y10.86%

5

5. Dividend

5.1 Amount

With a yearly dividend of 0.90%, COR is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.95, COR pays a better dividend. On top of this COR pays more dividend than 81.31% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.29, COR's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.9%

5.2 History

The dividend of COR has a limited annual growth rate of 5.42%.
COR has paid a dividend for at least 10 years, which is a reliable track record.
COR has decreased its dividend in the last 3 years.
Dividend Growth(5Y)5.42%
Div Incr Years2
Div Non Decr Years2
COR Yearly Dividends per shareCOR Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

30.18% of the earnings are spent on dividend by COR. This is a low number and sustainable payout ratio.
The dividend of COR is growing, but earnings are growing more, so the dividend growth is sustainable.
DP30.18%
EPS Next 2Y11.49%
EPS Next 3Y10.86%
COR Yearly Income VS Free CF VS DividendCOR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B
COR Dividend Payout.COR Dividend Payout, showing the Payout Ratio.COR Dividend Payout.PayoutRetained Earnings

CENCORA INC

NYSE:COR (2/21/2025, 8:10:36 PM)

After market: 241.43 0 (0%)

241.43

-2.03 (-0.83%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-05 2025-02-05/bmo
Earnings (Next)04-29 2025-04-29/amc
Inst Owners91.43%
Inst Owner Change36.16%
Ins Owners0.24%
Ins Owner Change9.73%
Market Cap46.77B
Analysts77.27
Price Target283.57 (17.45%)
Short Float %4.99%
Short Ratio6.56
Dividend
Industry RankSector Rank
Dividend Yield 0.9%
Yearly Dividend2.1
Dividend Growth(5Y)5.42%
DP30.18%
Div Incr Years2
Div Non Decr Years2
Ex-Date02-14 2025-02-14 (0.55)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.03%
Min EPS beat(2)2.68%
Max EPS beat(2)5.38%
EPS beat(4)4
Avg EPS beat(4)3.18%
Min EPS beat(4)1.86%
Max EPS beat(4)5.38%
EPS beat(8)8
Avg EPS beat(8)4.25%
EPS beat(12)12
Avg EPS beat(12)3.84%
EPS beat(16)15
Avg EPS beat(16)3.18%
Revenue beat(2)2
Avg Revenue beat(2)1.86%
Min Revenue beat(2)0.79%
Max Revenue beat(2)2.93%
Revenue beat(4)3
Avg Revenue beat(4)-0.09%
Min Revenue beat(4)-4.13%
Max Revenue beat(4)2.93%
Revenue beat(8)7
Avg Revenue beat(8)1.76%
Revenue beat(12)9
Avg Revenue beat(12)1.15%
Revenue beat(16)11
Avg Revenue beat(16)0.83%
PT rev (1m)-0.63%
PT rev (3m)4.21%
EPS NQ rev (1m)-4.51%
EPS NQ rev (3m)-1.61%
EPS NY rev (1m)2.93%
EPS NY rev (3m)3.26%
Revenue NQ rev (1m)0.61%
Revenue NQ rev (3m)2.8%
Revenue NY rev (1m)0.26%
Revenue NY rev (3m)1.45%
Valuation
Industry RankSector Rank
PE 16.99
Fwd PE 14.12
P/S 0.15
P/FCF N/A
P/OCF N/A
P/B 206.41
P/tB N/A
EV/EBITDA 12.44
EPS(TTM)14.21
EY5.89%
EPS(NY)17.1
Fwd EY7.08%
FCF(TTM)-3.29
FCFYN/A
OCF(TTM)-0.62
OCFYN/A
SpS1565.19
BVpS1.17
TBVpS-65.22
PEG (NY)1.31
PEG (5Y)1.2
Profitability
Industry RankSector Rank
ROA 2.02%
ROE 616.22%
ROCE 21.06%
ROIC 16.43%
ROICexc 21.11%
ROICexgc N/A
OM 1.01%
PM (TTM) 0.46%
GM 3.26%
FCFM N/A
ROA(3y)2.68%
ROA(5y)0.61%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)16.51%
ROIC(5y)15.55%
ROICexc(3y)21.56%
ROICexc(5y)21.55%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)21.17%
ROCE(5y)19.93%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y15.26%
ROICexc growth 5Y0.87%
OM growth 3Y-6.12%
OM growth 5Y-0.1%
PM growth 3Y-10.65%
PM growth 5Y1.52%
GM growth 3Y1.72%
GM growth 5Y3.69%
F-Score4
Asset Turnover4.39
Health
Industry RankSector Rank
Debt/Equity 26.2
Debt/FCF N/A
Debt/EBITDA 1.42
Cap/Depr 46.25%
Cap/Sales 0.17%
Interest Coverage 13.13
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.92
Quick Ratio 0.54
Altman-Z 4.99
F-Score4
WACC8.63%
ROIC/WACC1.9
Cap/Depr(3y)53.4%
Cap/Depr(5y)67.19%
Cap/Sales(3y)0.18%
Cap/Sales(5y)0.19%
Profit Quality(3y)175.45%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.14%
EPS 3Y14.11%
EPS 5Y14.21%
EPS Q2Q%13.72%
EPS Next Y13.02%
EPS Next 2Y11.49%
EPS Next 3Y10.86%
EPS Next 5Y10.76%
Revenue 1Y (TTM)11.64%
Revenue growth 3Y11.16%
Revenue growth 5Y10.36%
Sales Q2Q%12.78%
Revenue Next Year9.66%
Revenue Next 2Y8.29%
Revenue Next 3Y7.76%
Revenue Next 5Y7.34%
EBIT growth 1Y14.93%
EBIT growth 3Y4.36%
EBIT growth 5Y10.24%
EBIT Next Year28.14%
EBIT Next 3Y13.01%
EBIT Next 5Y5.18%
FCF growth 1Y-131.04%
FCF growth 3Y10.42%
FCF growth 5Y8.07%
OCF growth 1Y-104.68%
OCF growth 3Y9.35%
OCF growth 5Y8.25%